Researchers made a “huge breakthrough” when they did an experiment “purely out of curiosity” which solves “a decades-long ...

The Fremont, California-based contract development and manufacturing organization is planning another facility north of ...

The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis ...

Engineers and biologists at Dartmouth College have found that, just like word order affects meaning in a sentence, the ...

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival ...

Market Overview: The European CRISPR gene editing market has experienced significant expansion, driven by advancements in biotechnology and increasing investment in genetic research. With a compound ...

Gene syntax also affects the behavior of genetic circuits, and contributes to unpredictable outcomes in genetic networks.

Colorado State University startup GenoFAB has joined BioMADE, connecting with over 300 organizations nationwide to advance biomanufacturing innovation. GenoFAB contributes critical expertise in ...

IntroductionThe Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 ...

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, 'P134 Cell Injection,' which has received Investigational New Drug (IND) ...